Navigation Links
Spectrum Names Katherine Maynard Chief Operating Officer

Assumes New Leadership Post At Global Health Communications, Policy Firm

WASHINGTON, June 10 /PRNewswire-USNewswire/ -- Leading health communications and public affairs firm Spectrum named Katherine J. Maynard as its Chief Operating Officer, a new position.

"Katherine's 11-year track record of nothing less than success at Spectrum has earned her an uncommon respect among clients and fellow team members," said President and CEO John J. Seng, the firm's founder. "As COO, she will guide the firm to its potential as the agency of choice for organizations anywhere that seek to improve personal and societal health," Seng added.

"The health communications agency sector and the clients we serve are experiencing a time of marked change and uncertainty," said Maynard. "Nonetheless, Spectrum has increased its focus on health policy, public affairs and digital communications as client service and counseling opportunities," she added. "My mission as COO is to ensure that Spectrum continues to deliver excellence in everything we do, from issue campaigns to in-depth science communications."

Spectrum's Washington headquarters ranks as the largest health communications office in the Nation's capital, with 47 staff.

In 1998, Ms. Maynard relocated to Washington and joined Spectrum from one of the firm's charter clients, a biotechnology company. Since then, she has directed strategy and execution of communications programs for nationwide pharmaceutical product launches and patient advocacy communications campaigns, spanning the women's health research, oncology, dermatology, infertility, contraception and cardiology categories. She became Executive Vice President, Client Services in early 2007, and today counsels health industry, hospitals, medical professional societies and third-party organization clients of Spectrum.

At Spectrum, Maynard will assume responsibility for overall management of the firm's day-to-day operations, including client services, business development, finance and human resources.

2009 developments at Spectrum under Maynard's leadership include the opening of a New York office, the rebranding of the firm, and the launch of the Spectrum Health Value Study(TM) (, proprietary research that explores how Americans value health when they consider spending their own money.

Spectrum ( is one of the nation's leading health and science communications agencies. Independently owned, and founded by Seng in 1996, Spectrum is committed to achieving the goals of clients who are involved with issues, products, provider services or research in life and human health sciences. A full-service agency, Spectrum adopts an insight-driven approach in creating strategic frameworks for clients, supported by marketing communications, advocacy relations, public affairs, digital communications and design services. Spectrum provides global reach as the US partner and chair of GLOBALHealthPR (, an international partnership uniting some of the world's most successful independent healthcare public relations firms and their affiliates from major markets in Europe, Asia and the Americas.

SOURCE Spectrum
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-Spectrum Cervical Cancer Vaccine Shows Promise
2. Education Series Offered For Parents Of Children Diagnosed With An Autism Spectrum Disorder
3. For Medical Device Makers, Full Spectrum Software Releases Software Technology Report Called How to Survive in 2009 and Beyond
4. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
5. HBA Global Expo and Spa & Resort/Medical Aesthetics Expo to Offer Full Spectrum of the Product Development Cycle
6. Spectrum Surgical Instruments Announces: Quality Management System Certification
7. Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care
8. Occupational Therapy Practitioners Identify Early Signs Of Autism Spectrum Disorder, Help Families Participate In Daily Routines
9. Andrew Dallas, President of Full Spectrum Software Appointed to Medical Device and Diagnostic Industry Magazine Editorial Advisory Board
10. Spectrum Control Introduces Next Generation Harsh Environment Broadband Antenna
11. A Broad-Spectrum Antibiotic with Activity Against MRSA and Pseudomonas Aeruginosa Would Earn a Higher Patient Share in the U.S. than in Europe for the Treatment of Hospital-Acquired Pneumonia
Post Your Comments:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: